Global and United States Biologics Contract Manufacturing Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Biologics contract manufacturing organizations offer all services right from research and development to dosage preparation and packaging under one roof. Therefore, this factor serves to be an important growth indicator for the biologics contract manufacturing market.

Market Analysis and Insights: Global and United States Biologics Contract Manufacturing Market

This report focuses on global and United States Biologics Contract Manufacturing market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Biologics Contract Manufacturing market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, MABs accounting for % of the Biologics Contract Manufacturing global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Oncology was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Biologics Contract Manufacturing market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Biologics Contract Manufacturing Scope and Market Size
Biologics Contract Manufacturing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Biologics Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Biologics Contract Manufacturing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    MABs
    Recombinant Protein
    Others

Segment by Application
    Oncology
    Immunological Disorders
    Cardiovascular Disorders (CVDs)
    Hematological Disorders
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Wuxi Biologics
    Abzena Ltd.
    FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
    Boehringer Ingelheim GmbH
    Lonza
    SamsungBiologics
    Abbvie
    Catalent
    Bioreliance
    Thermo Fischer (Patheon)
    Eurofins CDMO

 1 Study Coverage
    1.1 Biologics Contract Manufacturing Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Biologics Contract Manufacturing Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Biologics Contract Manufacturing Market Size for the Year 2017-2028
        1.2.2 Global Biologics Contract Manufacturing Market Size for the Year 2017-2028
    1.3 Biologics Contract Manufacturing Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Biologics Contract Manufacturing in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Biologics Contract Manufacturing Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Biologics Contract Manufacturing Market Dynamics
        1.4.1 Biologics Contract Manufacturing Industry Trends
        1.4.2 Biologics Contract Manufacturing Market Drivers
        1.4.3 Biologics Contract Manufacturing Market Challenges
        1.4.4 Biologics Contract Manufacturing Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Biologics Contract Manufacturing by Type
    2.1 Biologics Contract Manufacturing Market Segment by Type
        2.1.1 MABs
        2.1.2 Recombinant Protein
        2.1.3 Others
    2.2 Global Biologics Contract Manufacturing Market Size by Type (2017, 2022 & 2028)
    2.3 Global Biologics Contract Manufacturing Market Size by Type (2017-2028)
    2.4 United States Biologics Contract Manufacturing Market Size by Type (2017, 2022 & 2028)
    2.5 United States Biologics Contract Manufacturing Market Size by Type (2017-2028)

 3 Biologics Contract Manufacturing by Application
    3.1 Biologics Contract Manufacturing Market Segment by Application
        3.1.1 Oncology
        3.1.2 Immunological Disorders
        3.1.3 Cardiovascular Disorders (CVDs)
        3.1.4 Hematological Disorders
        3.1.5 Others
    3.2 Global Biologics Contract Manufacturing Market Size by Application (2017, 2022 & 2028)
    3.3 Global Biologics Contract Manufacturing Market Size by Application (2017-2028)
    3.4 United States Biologics Contract Manufacturing Market Size by Application (2017, 2022 & 2028)
    3.5 United States Biologics Contract Manufacturing Market Size by Application (2017-2028)

 4 Global Biologics Contract Manufacturing Competitor Landscape by Company
    4.1 Global Biologics Contract Manufacturing Market Size by Company
        4.1.1 Top Global Biologics Contract Manufacturing Companies Ranked by Revenue (2021)
        4.1.2 Global Biologics Contract Manufacturing Revenue by Player (2017-2022)
    4.2 Global Biologics Contract Manufacturing Concentration Ratio (CR)
        4.2.1 Biologics Contract Manufacturing Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Biologics Contract Manufacturing in 2021
        4.2.3 Global Biologics Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Biologics Contract Manufacturing Headquarters, Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Biologics Contract Manufacturing Headquarters and Area Served
        4.3.2 Global Biologics Contract Manufacturing Companies Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Biologics Contract Manufacturing Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Biologics Contract Manufacturing Market Size by Company
        4.5.1 Top Biologics Contract Manufacturing Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Biologics Contract Manufacturing Revenue by Players (2020, 2021 & 2022)

 5 Global Biologics Contract Manufacturing Market Size by Region
    5.1 Global Biologics Contract Manufacturing Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Biologics Contract Manufacturing Market Size by Region (2017-2028)
        5.2.1 Global Biologics Contract Manufacturing Market Size by Region: 2017-2022
        5.2.2 Global Biologics Contract Manufacturing Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
        6.1.2 North America Biologics Contract Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Biologics Contract Manufacturing Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
        6.3.2 Europe Biologics Contract Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
        6.4.2 Latin America Biologics Contract Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Biologics Contract Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Wuxi Biologics
        7.1.1 Wuxi Biologics Company Details
        7.1.2 Wuxi Biologics Business Overview
        7.1.3 Wuxi Biologics Biologics Contract Manufacturing Introduction
        7.1.4 Wuxi Biologics Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.1.5 Wuxi Biologics Recent Development
    7.2 Abzena Ltd.
        7.2.1 Abzena Ltd. Company Details
        7.2.2 Abzena Ltd. Business Overview
        7.2.3 Abzena Ltd. Biologics Contract Manufacturing Introduction
        7.2.4 Abzena Ltd. Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.2.5 Abzena Ltd. Recent Development
    7.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
        7.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
        7.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
        7.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Introduction
        7.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
    7.4 Boehringer Ingelheim GmbH
        7.4.1 Boehringer Ingelheim GmbH Company Details
        7.4.2 Boehringer Ingelheim GmbH Business Overview
        7.4.3 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Introduction
        7.4.4 Boehringer Ingelheim GmbH Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.4.5 Boehringer Ingelheim GmbH Recent Development
    7.5 Lonza
        7.5.1 Lonza Company Details
        7.5.2 Lonza Business Overview
        7.5.3 Lonza Biologics Contract Manufacturing Introduction
        7.5.4 Lonza Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.5.5 Lonza Recent Development
    7.6 SamsungBiologics
        7.6.1 SamsungBiologics Company Details
        7.6.2 SamsungBiologics Business Overview
        7.6.3 SamsungBiologics Biologics Contract Manufacturing Introduction
        7.6.4 SamsungBiologics Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.6.5 SamsungBiologics Recent Development
    7.7 Abbvie
        7.7.1 Abbvie Company Details
        7.7.2 Abbvie Business Overview
        7.7.3 Abbvie Biologics Contract Manufacturing Introduction
        7.7.4 Abbvie Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.7.5 Abbvie Recent Development
    7.8 Catalent
        7.8.1 Catalent Company Details
        7.8.2 Catalent Business Overview
        7.8.3 Catalent Biologics Contract Manufacturing Introduction
        7.8.4 Catalent Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.8.5 Catalent Recent Development
    7.9 Bioreliance
        7.9.1 Bioreliance Company Details
        7.9.2 Bioreliance Business Overview
        7.9.3 Bioreliance Biologics Contract Manufacturing Introduction
        7.9.4 Bioreliance Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.9.5 Bioreliance Recent Development
    7.10 Thermo Fischer (Patheon)
        7.10.1 Thermo Fischer (Patheon) Company Details
        7.10.2 Thermo Fischer (Patheon) Business Overview
        7.10.3 Thermo Fischer (Patheon) Biologics Contract Manufacturing Introduction
        7.10.4 Thermo Fischer (Patheon) Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.10.5 Thermo Fischer (Patheon) Recent Development
    7.11 Eurofins CDMO
        7.11.1 Eurofins CDMO Company Details
        7.11.2 Eurofins CDMO Business Overview
        7.11.3 Eurofins CDMO Biologics Contract Manufacturing Introduction
        7.11.4 Eurofins CDMO Revenue in Biologics Contract Manufacturing Business (2017-2022)
        7.11.5 Eurofins CDMO Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Biologics Contract Manufacturing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Biologics Contract Manufacturing Market Trends
    Table 3. Biologics Contract Manufacturing Market Drivers
    Table 4. Biologics Contract Manufacturing Market Challenges
    Table 5. Biologics Contract Manufacturing Market Restraints
    Table 6. Global Biologics Contract Manufacturing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Biologics Contract Manufacturing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Biologics Contract Manufacturing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Biologics Contract Manufacturing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Biologics Contract Manufacturing Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Biologics Contract Manufacturing Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Biologics Contract Manufacturing Revenue Share by Player, 2017-2022
    Table 13. Global Biologics Contract Manufacturing Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Biologics Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Contract Manufacturing as of 2021)
    Table 15. Top Players of Biologics Contract Manufacturing in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Biologics Contract Manufacturing Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Biologics Contract Manufacturing Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Biologics Contract Manufacturing Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Biologics Contract Manufacturing Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Biologics Contract Manufacturing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Biologics Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Biologics Contract Manufacturing Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Biologics Contract Manufacturing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Biologics Contract Manufacturing Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Biologics Contract Manufacturing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Biologics Contract Manufacturing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Biologics Contract Manufacturing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Wuxi Biologics Company Details
    Table 31. Wuxi Biologics Business Overview
    Table 32. Wuxi Biologics Biologics Contract Manufacturing Product
    Table 33. Wuxi Biologics Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 34. Wuxi Biologics Recent Development
    Table 35. Abzena Ltd. Company Details
    Table 36. Abzena Ltd. Business Overview
    Table 37. Abzena Ltd. Biologics Contract Manufacturing Product
    Table 38. Abzena Ltd. Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 39. Abzena Ltd. Recent Development
    Table 40. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
    Table 41. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
    Table 42. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Product
    Table 43. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 44. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
    Table 45. Boehringer Ingelheim GmbH Company Details
    Table 46. Boehringer Ingelheim GmbH Business Overview
    Table 47. Boehringer Ingelheim GmbH Biologics Contract Manufacturing Product
    Table 48. Boehringer Ingelheim GmbH Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 49. Boehringer Ingelheim GmbH Recent Development
    Table 50. Lonza Company Details
    Table 51. Lonza Business Overview
    Table 52. Lonza Biologics Contract Manufacturing Product
    Table 53. Lonza Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 54. Lonza Recent Development
    Table 55. SamsungBiologics Company Details
    Table 56. SamsungBiologics Business Overview
    Table 57. SamsungBiologics Biologics Contract Manufacturing Product
    Table 58. SamsungBiologics Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 59. SamsungBiologics Recent Development
    Table 60. Abbvie Company Details
    Table 61. Abbvie Business Overview
    Table 62. Abbvie Biologics Contract Manufacturing Product
    Table 63. Abbvie Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 64. Abbvie Recent Development
    Table 65. Catalent Company Details
    Table 66. Catalent Business Overview
    Table 67. Catalent Biologics Contract Manufacturing Product
    Table 68. Catalent Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 69. Catalent Recent Development
    Table 70. Bioreliance Company Details
    Table 71. Bioreliance Business Overview
    Table 72. Bioreliance Biologics Contract Manufacturing Product
    Table 73. Bioreliance Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 74. Bioreliance Recent Development
    Table 75. Thermo Fischer (Patheon) Company Details
    Table 76. Thermo Fischer (Patheon) Business Overview
    Table 77. Thermo Fischer (Patheon) Biologics Contract Manufacturing Product
    Table 78. Thermo Fischer (Patheon) Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 79. Thermo Fischer (Patheon) Recent Development
    Table 80. Eurofins CDMO Company Details
    Table 81. Eurofins CDMO Business Overview
    Table 82. Eurofins CDMO Biologics Contract Manufacturing Product
    Table 83. Eurofins CDMO Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 84. Eurofins CDMO Recent Development
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biologics Contract Manufacturing Product Picture
    Figure 2. Global Biologics Contract Manufacturing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Biologics Contract Manufacturing Market Size 2017-2028 (US$ Million)
    Figure 4. United States Biologics Contract Manufacturing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Biologics Contract Manufacturing Market Size 2017-2028 (US$ Million)
    Figure 6. United States Biologics Contract Manufacturing Market Share in Global 2017-2028
    Figure 7. Biologics Contract Manufacturing Report Years Considered
    Figure 8. Product Picture of MABs
    Figure 9. Product Picture of Recombinant Protein
    Figure 10. Product Picture of Others
    Figure 11. Global Biologics Contract Manufacturing Market Share by Type in 2022 & 2028
    Figure 12. Global Biologics Contract Manufacturing Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Biologics Contract Manufacturing Market Share by Type (2017-2028)
    Figure 14. United States Biologics Contract Manufacturing Market Share by Type in 2022 & 2028
    Figure 15. United States Biologics Contract Manufacturing Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Biologics Contract Manufacturing Market Share by Type (2017-2028)
    Figure 17. Product Picture of Oncology
    Figure 18. Product Picture of Immunological Disorders
    Figure 19. Product Picture of Cardiovascular Disorders (CVDs)
    Figure 20. Product Picture of Hematological Disorders
    Figure 21. Product Picture of Others
    Figure 22. Global Biologics Contract Manufacturing Market Share by Application in 2022 & 2028
    Figure 23. Global Biologics Contract Manufacturing Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Biologics Contract Manufacturing Market Share by Application (2017-2028)
    Figure 25. United States Biologics Contract Manufacturing Market Share by Application in 2022 & 2028
    Figure 26. United States Biologics Contract Manufacturing Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Biologics Contract Manufacturing Market Share by Application (2017-2028)
    Figure 28. North America Biologics Contract Manufacturing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. United States Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Biologics Contract Manufacturing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Biologics Contract Manufacturing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. China Taiwan Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Biologics Contract Manufacturing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Colombia Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Biologics Contract Manufacturing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. UAE Biologics Contract Manufacturing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Wuxi Biologics Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 57. Abzena Ltd. Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 58. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 59. Boehringer Ingelheim GmbH Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 60. Lonza Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 61. SamsungBiologics Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 62. Abbvie Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 63. Catalent Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 64. Bioreliance Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 65. Thermo Fischer (Patheon) Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 66. Eurofins CDMO Revenue Growth Rate in Biologics Contract Manufacturing Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed

Biologics contract manufacturing organizations offer all services right from research and development to dosage preparation and packaging under one roof. Therefore, this factor serves to be an important growth indicator for the biologics contract manufacturing market.

Market Analysis and Insights: Global and United States Biologics Contract Manufacturing Market

This report focuses on global and United States Biologics Contract Manufacturing market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Biologics Contract Manufacturing market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, MABs accounting for % of the Biologics Contract Manufacturing global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Oncology was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Biologics Contract Manufacturing market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Biologics Contract Manufacturing Scope and Market Size
Biologics Contract Manufacturing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Biologics Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Biologics Contract Manufacturing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    MABs
    Recombinant Protein
    Others

Segment by Application
    Oncology
    Immunological Disorders
    Cardiovascular Disorders (CVDs)
    Hematological Disorders
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Wuxi Biologics
    Abzena Ltd.
    FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
    Boehringer Ingelheim GmbH
    Lonza
    SamsungBiologics
    Abbvie
    Catalent
    Bioreliance
    Thermo Fischer (Patheon)
    Eurofins CDMO